Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ILCFirst Evidence That Hep C Drugs Curb Liver TransplantsPatients are being delisted from liver transplant wait lists because of direct-acting antiviral therapy, investigators report, but there are no long-term data to predict their future, experts caution.
Once-Daily Oral Combination Clears Hepatitis C in 95%After 12 weeks of treatment with a fixed-dose combination of grazoprevir and elbasvir, hepatitis C RNA levels were undetectable
in 95% of patients, a new study has shown.
Valerio Nobili, MD Chief, Hepatometabolic Unit; Director, Liver Research Unit, Bambino Gesù Children's Hospital, Rome, Italy Presentation: Differences between adult and adolescent NAFLD - Implications for follow up and therapy Date: April 13, 2016
Nancy Reau, MD University of Southern California, Los Angeles Presentation: EASL recommendations on treatment of hepatitis C 2016: update coming Date: April 16, 2016
Valerio Nobili, MD
Nancy Reau, MD
